Clinical Trial Update: S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

View source ↗

Summary

SWOG's S0334 trial, which analyzes chromosomal abnormalities in patients with newly diagnosed multiple myeloma and other blood diseases, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma
• Plasma Cell Neoplasms

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Status: COMPLETED